Back to News
Market Impact: 0.45

Warren Buffett Detailed Fundamental Analysis

ACNNDAQ
Company FundamentalsAnalyst InsightsCorporate EarningsCapital Returns (Dividends / Buybacks)Technology & Innovation
Warren Buffett Detailed Fundamental Analysis

Validea's guru fundamental report rates Accenture PLC (ACN) at 85% using its Warren Buffett-inspired 'Patient Investor' model, indicating strong alignment with criteria for long-term, predictable profitability, low debt, and reasonable valuation. The large-cap computer services firm notably passed key fundamental tests including earnings predictability, free cash flow, and return on equity, suggesting it meets the stringent requirements favored by Buffett's strategy.

Analysis

Accenture PLC (ACN) has been rated highly, scoring 85%, by Validea's 'Patient Investor' model, which emulates the investment principles of Warren Buffett. This score indicates a strong alignment with criteria favoring companies with predictable long-term profitability, low debt, and reasonable valuations. The analysis highlights that ACN, a large-cap growth stock in the Computer Services industry, passed critical fundamental tests including earnings predictability, debt service, return on equity, return on total capital, and free cash flow generation. This suite of positive indicators suggests robust financial health and operational efficiency. The only area not receiving a full pass was 'Share Repurchase', which was deemed 'Neutral'. The overall assessment, framed by a strongly positive sentiment score of 0.75, positions ACN as a high-quality company that meets the stringent requirements of a value-oriented, long-term investment strategy.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment